ALK announces Health Canada approval of ITULATEK SLIT-tablets for the treatment of tree pollen allergy

by NASDAQ Market News April 20, 2020

NASDAQ Market News
Click here to email author

Authentic Heroes To Supply Personal Protective Equipment To Front Line Service Providers

Helsinn Therapeutics (U.S.), Inc. waives copay fees for cancer-treating drug VALCHLOR® (mechlorethamine) gel to ensure eligible patients have access to treatment during the COVID-19 crisis

Ads